Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Almujtama Alraida Medical CoSAU:9592 10 ROC (Joel Greenblatt) % is 11.37% as of Dec. 2025, which is 75% below its 10-year median of 44.78. GuruFocus rates SAU:9592 with a GF Score™ of 10/100. The stock has 4 warning signs investors should review. Among 674 Healthcare Providers & Services companies, Almujtama Alraida Medical Co ranks better than 56.08% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Almujtama Alraida Medical Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 11.37%.
The historical rank and industry rank for Almujtama Alraida Medical Co's ROC (Joel Greenblatt) % or its related term are showing as below:
SAU:9592'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.29 Med: 44.78 Max: 191.64
Current: 16.26
During the past 5 years, Almujtama Alraida Medical Co's highest ROC (Joel Greenblatt) % was 191.64%. The lowest was 7.29%. And the median was 44.78%.
SAU:9592's ROC (Joel Greenblatt) % is ranked better than 56.08% of 674
companies
in the Healthcare Providers & Services industry
Industry Median: 12.5
vs SAU:9592: 16.26
Almujtama Alraida Medical Co (SAU:9592) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almujtama Alraida Medical Co ROC (Joel Greenblatt) % Chart
Almujtama Alraida Medical Co ROC (Joel Greenblatt) % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almujtama Alraida Medical Co ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Almujtama Alraida Medical Co's ROC (Joel Greenblatt) % falls into.
Almujtama Alraida Medical Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 11.37% mean?
Almujtama Alraida Medical Co (SAU:9592) has a ROC (Joel Greenblatt) % of 11.37% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Almujtama Alraida Medical Co and its competitors. This is 75% below median its historical median of 44.78. Over the past decade, Almujtama Alraida Medical Co's ROC (Joel Greenblatt) % has ranged from 7.29 to 191.64. According to the industry distribution chart, Almujtama Alraida Medical Co ranks #296 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 43.9%.
Is Almujtama Alraida Medical Co's ROC (Joel Greenblatt) % too high?
Almujtama Alraida Medical Co's current ROC (Joel Greenblatt) % of 11.37% is 75% below median its 10-year median of 44.78. Over the past 10 years, this metric has ranged from a low of 7.29 to a high of 191.64. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.50. Almujtama Alraida Medical Co's value of 11.37% is 9% below this industry median. Based on the distribution chart, Almujtama Alraida Medical Co ranks #296 out of 674 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Almujtama Alraida Medical Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Almujtama Alraida Medical Co's ROC (Joel Greenblatt) % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Almujtama Alraida Medical Co ranks #296 out of 674 companies for ROC (Joel Greenblatt) %. This puts Almujtama Alraida Medical Co in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.50. Almujtama Alraida Medical Co's value of 11.37% is 9% below this benchmark. Historically, Almujtama Alraida Medical Co's own ROC (Joel Greenblatt) % has ranged from 7.29 to 191.64 over the past decade. While the company's 10-year median is 44.78 vs. the industry median of 12.50, Almujtama Alraida Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.50, based on 674 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Almujtama Alraida Medical Co's current ROC (Joel Greenblatt) % of 11.37% is 9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Almujtama Alraida Medical Co and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almujtama Alraida Medical Co's current ROC (Joel Greenblatt) % is 11.37%, which is 75% below median its own 10-year median of 44.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almujtama Alraida Medical Co stock overvalued right now?
Almujtama Alraida Medical Co (SAU:9592) has a current ROC (Joel Greenblatt) % of 11.37%. The current ROC (Joel Greenblatt) % is 11.37%, which is 75% below median its 10-year median of 44.78 and 9% below the Healthcare Providers & Services industry median of 12.50. Almujtama Alraida Medical Co's overall GF Score™ is 10/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Almujtama Alraida Medical Co (SAU:9592), the current ROC (Joel Greenblatt) % is 11.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retailing pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia.
10GF Score
Get the complete analysis for SAU:9592
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9592 has been successfully added to your 
